Meeting
2019 ASCO Annual Meeting
High temporal variability of clinical side effects with and without adjuvant chemotherapy in 4,684 early breast cancer patients in the CANTO trial.
Authors
Paul H. Cottu
Institut Curie, Paris, France
Paul H. Cottu , Marie-Laure Tanguy , Enora Laas , Olivier Tredan , Sylvie Giacchetti , Sophie Guillermet , Jean-Marc Ferrero , Olivier Rigal , Carole Tarpin , Mario Campone , Christelle Levy , Patrick Soulie , Laurence Vanlemmens , Marion Fournié , Christelle Jouannaud , Sibille Everhard , Jerome Lemonnier , Patrick Arveux , Ines Maria Vaz Duarte Luis , Fabrice Andre
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Symptoms and Survivorship
Track
Symptom Science and Palliative Care
Sub Track
Late and Long-Term Adverse Effects
Clinical Trial Registration Number
NCT01993498
Citation
J Clin Oncol 37, 2019 (suppl; abstr 11566)
DOI
10.1200/JCO.2019.37.15_suppl.11566
Abstract #
11566
Poster Bd #
258
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Annual Meeting
Adjuvant dynamic marker-adjusted personalized therapy comparing endocrine therapy plus ribociclib versus chemotherapy in intermediate-risk HR+/HER2- early breast cancer: ADAPTcycle.
First Author: Nadia Harbeck
Poster
2022 ASCO Annual Meeting
CT scan versus bioelectrical impedance spectrometry sarcopenia assessment to predict chemotherapy toxicity in early breast cancer.
First Author: Gabriel Aleixo
Poster
2021 ASCO Annual Meeting
Assessing the risk of severe post-treatment (tx) cancer-related fatigue (CRF) among breast cancer survivors (BCS) in the CANcer TOxicity (CANTO) cohort.
First Author: Antonio Di Meglio
Poster
2019 ASCO Annual Meeting
Return to work after breast cancer: Comprehensive longitudinal analyses of its determinants.
First Author: Agnes Dumas